12-64016975-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_020762.4(SRGAP1):​c.452A>T​(p.His151Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000193 in 1,552,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

SRGAP1
NM_020762.4 missense

Scores

2
7
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.75
Variant links:
Genes affected
SRGAP1 (HGNC:17382): (SLIT-ROBO Rho GTPase activating protein 1) The protein encoded by this gene is a GTPase activator, working with the GTPase CDC42 to negatively regulate neuronal migration. The encoded protein interacts with the transmembrane receptor ROBO1 to inactivate CDC42. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3634931).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRGAP1NM_020762.4 linkc.452A>T p.His151Leu missense_variant Exon 4 of 22 ENST00000355086.8 NP_065813.1 Q7Z6B7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRGAP1ENST00000355086.8 linkc.452A>T p.His151Leu missense_variant Exon 4 of 22 1 NM_020762.4 ENSP00000347198.3 Q7Z6B7-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
7.14e-7
AC:
1
AN:
1400014
Hom.:
0
Cov.:
23
AF XY:
0.00000143
AC XY:
1
AN XY:
698616
show subpopulations
African (AFR)
AF:
0.0000312
AC:
1
AN:
32088
American (AMR)
AF:
0.00
AC:
0
AN:
43338
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25566
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39066
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81306
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5616
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1062218
Other (OTH)
AF:
0.00
AC:
0
AN:
58226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152190
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 10, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.452A>T (p.H151L) alteration is located in exon 4 (coding exon 4) of the SRGAP1 gene. This alteration results from a A to T substitution at nucleotide position 452, causing the histidine (H) at amino acid position 151 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Uncertain
0.032
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
25
DANN
Benign
0.97
DEOGEN2
Benign
0.33
T;T;T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D;D;.
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.36
T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
1.3
L;.;.
PhyloP100
6.8
PrimateAI
Pathogenic
0.79
T
PROVEAN
Pathogenic
-4.7
D;.;D
REVEL
Benign
0.21
Sift
Uncertain
0.0090
D;.;D
Sift4G
Uncertain
0.015
D;D;D
Polyphen
0.33
B;P;P
Vest4
0.63
MutPred
0.57
Gain of ubiquitination at K156 (P = 0.0633);.;.;
MVP
0.49
MPC
1.2
ClinPred
0.89
D
GERP RS
5.6
Varity_R
0.38
gMVP
0.77
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1430830690; hg19: chr12-64410755; API